-+ 0.00%
-+ 0.00%
-+ 0.00%

LILLY'S RETATRUTIDE DELIVERED GREATER A1C REDUCTION AND MORE THAN DOUBLE THE WEIGHT LOSS OF OZEMPIC'S HIGHEST APPROVED DOSE IN HEAD-TO-HEAD TRIAL

Reuters·10/28/2026 10:46:18